These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22666141)
21. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Clark FJ; Gregg R; Piper K; Dunnion D; Freeman L; Griffiths M; Begum G; Mahendra P; Craddock C; Moss P; Chakraverty R Blood; 2004 Mar; 103(6):2410-6. PubMed ID: 14604970 [TBL] [Abstract][Full Text] [Related]
22. T helper 17 and regulatory T-cell profile and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in pediatric patients with beta-thalassemia. Bayegi SN; Hamidieh AA; Behfar M; Saghazadeh A; Bozorgmehr M; Karamlou Y; Shekarabi M; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Rezaei N Transpl Immunol; 2023 Apr; 77():101803. PubMed ID: 36842567 [TBL] [Abstract][Full Text] [Related]
23. Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Wolf D; Wolf AM; Fong D; Rumpold H; Strasak A; Clausen J; Nachbaur D Transplantation; 2007 Apr; 83(8):1107-13. PubMed ID: 17452902 [TBL] [Abstract][Full Text] [Related]
24. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation. Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226 [TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease. Imanguli MM; Cowen EW; Rose J; Dhamala S; Swaim W; Lafond S; Yagi B; Gress RE; Pavletic SZ; Hakim FT Leukemia; 2014 Oct; 28(10):2016-27. PubMed ID: 24577531 [TBL] [Abstract][Full Text] [Related]
26. [Relationship between CD4(+)CD25(+) regulatory T cells, IL-2, TGF-beta and acute graft-versus host disease after allogeneic hematopoietic stem cell transplantation]. Niu YY; Ma LM; Zhou Y; Ren RR Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):735-9. PubMed ID: 20561440 [TBL] [Abstract][Full Text] [Related]
27. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse. Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739 [TBL] [Abstract][Full Text] [Related]
28. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Li Q; Zhai Z; Xu X; Shen Y; Zhang A; Sun Z; Liu H; Geng L; Wang Y Leuk Res; 2010 Sep; 34(9):1158-68. PubMed ID: 20409584 [TBL] [Abstract][Full Text] [Related]
29. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation]. Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019 [TBL] [Abstract][Full Text] [Related]
30. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation. Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293 [TBL] [Abstract][Full Text] [Related]
31. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial. Gooptu M; Kim HT; Chen YB; Rybka W; Artz A; Boyer M; Johnston L; McGuirk J; Shea TC; Jagasia M; Shaughnessy PJ; Reynolds CG; Fields M; Alyea EP; Ho VT; Glavin F; Dipersio JF; Westervelt P; Ritz J; Soiffer RJ Biol Blood Marrow Transplant; 2018 Nov; 24(11):2216-2223. PubMed ID: 30006305 [TBL] [Abstract][Full Text] [Related]
32. Phenotypical and functional characterization of bone marrow mesenchymal stem cells in patients with chronic graft-versus-host disease. Wang B; Hu Y; Liu L; Hu K; Tie R; He Y; Fu S; Zhu N; Luo Y; Yu X; Huang H Biol Blood Marrow Transplant; 2015 Jun; 21(6):1020-8. PubMed ID: 25708216 [TBL] [Abstract][Full Text] [Related]
33. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease. Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167 [TBL] [Abstract][Full Text] [Related]
35. Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells. Ukena SN; Grosse J; Mischak-Weissinger E; Buchholz S; Stadler M; Ganser A; Franzke A Ann Hematol; 2011 Feb; 90(2):213-8. PubMed ID: 20859740 [TBL] [Abstract][Full Text] [Related]